Lanxess to revise strategy after sales and earnings plummet; 2014 target unrealistic
07:54 AM | August 6, 2013 | Natasha Alperowicz
Lanxess today reported a 95% decline in second-quarter net income to €9 million ($11.9 million) on sales down 12% to €2.1 billion. Second-quarter Ebitda was down 45% at €198 million, corresponding to...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.